Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer.
Zhi J, Chen E, Major P, Burns I, Robinson B, McKendrick J, Rittweger K, Abt M, Goldstein D. Zhi J, et al. Among authors: goldstein d. Cancer Chemother Pharmacol. 2011 Nov;68(5):1199-206. doi: 10.1007/s00280-011-1606-z. Epub 2011 Mar 16. Cancer Chemother Pharmacol. 2011. PMID: 21409383 Clinical Trial.
A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601.
Findlay M, Storey D, Gebski V, Hargreaves C, Cullingford G, Boyer M, Trotter J, Archer S, Davidson A, Johnston P, Yuen J, Dhillon H, Della-Fiorentina S, Richardson G, Truskett P, Goldstein D; AGITG. Findlay M, et al. Among authors: goldstein d. ANZ J Surg. 2007 Apr;77(4):247-52. doi: 10.1111/j.1445-2197.2007.04027.x. ANZ J Surg. 2007. PMID: 17388828 Clinical Trial.
Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.
Jaeger U, Trneny M, Melzer H, Praxmarer M, Nawarawong W, Ben Yehuda D, Goldstein D, Mihaljevic B, Ilhan O, Ballova V, Hedenus M, Hsiao LT, Au WY, Burgstaller S, Weidinger G, Keil F, Dittrich C, Skrabs C, Klingler A, Chott A, Fridrik MA, Greil R; AGMT-NHL13 Investigators. Jaeger U, et al. Among authors: goldstein d. Haematologica. 2015 Jul;100(7):955-63. doi: 10.3324/haematol.2015.125344. Epub 2015 Apr 24. Haematologica. 2015. PMID: 25911553 Free PMC article. Clinical Trial.
Optimizing Osteotomy Geometries in Posterolateral Mandibulectomies.
Kim HAJ, De Biasio MJ, Forte V, Gilbert RW, Irish JC, Goldstein DP, de Almeida JR, Hanasono MM, Yu P, Chepeha DB, Looi T, Yao CMKL. Kim HAJ, et al. Among authors: goldstein dp. JAMA Otolaryngol Head Neck Surg. 2024 Oct 31. doi: 10.1001/jamaoto.2024.3246. Online ahead of print. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 39480439
Validation of the Online Collaborative Ocular Tuberculosis Study Calculator for Tubercular Uveitis.
Zhang L, Rojas-Carabali W, Choo SS, Thng ZX, Lim YH, Lee B, Jun SW, Patnaik G, Biswas J, Agarwal A, Testi I, Mahajan S, Kempen JH, Smith JR, McCluskey P, Kon OM, Nguyen QD, Pavesio C, Gupta V, Agrawal R; Collaborative Ocular Tuberculosis Study (COTS) Group. Zhang L, et al. JAMA Ophthalmol. 2024 Oct 31. doi: 10.1001/jamaophthalmol.2024.4567. Online ahead of print. JAMA Ophthalmol. 2024. PMID: 39480402
Impact of Postoperative Neck Radiotherapy Volumes on Long-Term Unstimulated Saliva Flow Following Primary Surgery and Ipsilateral Neck Dissection for Oral Cavity Squamous Cell Carcinoma.
Rooney CM, Huang SH, Su J, Bratman S, Cho J, de Almeida J, Glogauer M, Goldstein D, Hahn E, Hosni A, Hope A, Irish J, Kim J, O'Sullivan B, Ringash J, Spreafico A, Tsai J, Waldron J, Yao C, Watson E, McPartlin A. Rooney CM, et al. Among authors: goldstein d. Head Neck. 2024 Oct 30. doi: 10.1002/hed.27988. Online ahead of print. Head Neck. 2024. PMID: 39474724
Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice.
Branford JA, Bodaghi B, Ferreira LB, McCluskey PJ, Thorne JE, Matthews JM; International Study Group for Systemic Immunomodulatory Drug Treatment of Non‐Infectious Uveitis; Smith JR. Branford JA, et al. Br J Ophthalmol. 2024 Oct 29:bjo-2024-326239. doi: 10.1136/bjo-2024-326239. Online ahead of print. Br J Ophthalmol. 2024. PMID: 39472042
Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer Outcomes.
Wihlidal J, Esemezie AO, Huang SH, Watson E, Gilbert RW, Waldron J, Gullane PJ, Hope A, Irish JC, O'Sullivan B, Chepeha DB, Kim JJH, Brown D, Cho BCJ, Witterick IJ, Monteiro E, Davies JC, Ringash J, Goldstein DP, Bratman S, Bayley A, de Almeida JR, Chan TCY, Hosni A, Yao CMKL. Wihlidal J, et al. Among authors: goldstein dp. Ann Surg Oncol. 2024 Oct 28. doi: 10.1245/s10434-024-16385-4. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39467971
Efficacy of Subcutaneous and Intravenous Tocilizumab in Noninfectious Uveitis.
Kherani S, Alapati A, Begaj T, Atlas S, Koreishi A, Janetos T, Faia LJ, Goldstein DA. Kherani S, et al. Among authors: goldstein da. Ophthalmology. 2024 Oct 15:S0161-6420(24)00630-4. doi: 10.1016/j.ophtha.2024.10.010. Online ahead of print. Ophthalmology. 2024. PMID: 39419184
4,120 results